RT @terrywahls: This paper reviews the recommendations for starting drugs in the setting of clinically isolated syndrome. https://t.co/iI4O…
This paper reviews the recommendations for starting drugs in the setting of clinically isolated syndrome. https://t.co/iI4OFRE4mg Whatever you decide about using drugs you will get the best outcome by also utilizing a therapeutic diet and lifestyle progra
RT @terrywahls: There is a strong desire to prevent disability for those who will develop multiple sclerosis. This paper reviews the recomm…
RT @terrywahls: There is a strong desire to prevent disability for those who will develop multiple sclerosis. This paper reviews the recomm…
There is a strong desire to prevent disability for those who will develop multiple sclerosis. This paper reviews the recommendations for starting drugs in the setting of clinically isolated syndrome. https://t.co/nCZZe4E7yF Whatever you decide about using
RT @GavinGiovannoni: A review of the treatment of CIS. Pity we can't use oral cladribine in CIS; it has by far the best data, but both the…
A review of the treatment of CIS. Pity we can't use oral cladribine in CIS; it has by far the best data, but both the EMA and FDA bottled on extending the use of cladribine to CIS. Why? #ClinicSpeak https://t.co/KQSO46FGHH https://t.co/fgMUNFMJiA